Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc. financial statements

Neuphoria Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 1.17M10-K
Net income−USD 13.45M10-K
Cash and equivalentsUSD 19.87M10-Q
Total debtUSD 34.34KEODHD

Neuphoria Therapeutics Inc. financials on 6ix · Neuphoria Therapeutics Inc. on 6ix